BARROS LLC LIMITED
Company number 12845030 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
BARROS LLC LIMITED - Analysis Report
Company Number: 12845030
Analysis Date: 2025-07-20 11:02 UTC
Financial Health Assessment for BARROS LLC LIMITED (As at 31 August 2024)
1. Financial Health Score: D
Explanation:
The company shows persistent net liabilities over multiple years, with a negative net asset position of approximately £87k. This indicates financial distress or imbalance. A "D" grade reflects significant weaknesses in financial stability, particularly in liquidity and solvency, which require urgent attention but do not yet indicate imminent failure.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £602,929 | Stable, representing property or long-term investments. |
| Current Assets | £34,749 | Low liquid assets relative to liabilities. |
| Current Liabilities | £410,906 | High short-term debt obligations causing liquidity strain. |
| Net Current Assets | £-276,865 | Negative working capital; cash flow likely tight. |
| Total Assets Less Current Liabilities | £326,064 | Positive excluding long-term debt; assets are substantial. |
| Creditors > 1 Year | £410,906 | Large long-term liabilities exceed asset buffer. |
| Net Assets / Shareholders Funds | £-86,954 | Persistent negative equity indicates insolvency risk. |
| Share Capital | £100 | Minimal equity investment; limited capital buffer. |
| Average Number of Employees | 1 | Very small operation; limited scale. |
Interpretation of Vital Signs:
- The company’s fixed assets are substantial, indicating investment in real estate as per SIC codes.
- However, current liabilities far exceed current assets, signaling a "symptom" of liquidity distress—akin to a patient having poor blood circulation.
- Negative net assets reflect a "diagnostic sign" of financial weakness or insolvency risk, meaning liabilities are greater than assets, which is a critical warning.
- Minimal equity capital invested means the "immune system" (financial resilience) is weak.
- The small staff size suggests limited operational complexity, but also limited human resources to manage turnaround.
3. Diagnosis
The financial data paints a picture of a company heavily leveraged against its real estate holdings, with persistent negative working capital and net liabilities over the last several years. This pattern is like a patient with chronic symptoms indicating underlying organ stress—in this case, structural financial weakness.
- Liquidity Risk: Negative net current assets indicate difficulty covering short-term obligations with available liquid assets. Cash flow is likely strained.
- Solvency Risk: Negative shareholders’ funds mean the company’s debts exceed its total assets, a serious "symptom" of insolvency risk.
- Asset Quality: Fixed assets are stable but may be illiquid or overvalued relative to market conditions.
- Leverage: The company relies heavily on creditor financing both short and long term, increasing financial risk if asset values decline or cash inflows falter.
- Operational Scale: Minimal employees and small share capital suggest limited capacity for organic growth or absorbing shocks.
Overall Condition: Financially fragile with significant risks in liquidity and solvency. The company is in a state of financial distress but not yet in liquidation or administration.
4. Recommendations
To improve financial wellness and avert crisis, consider the following targeted actions:
Enhance Liquidity ("Boost Circulation"):
- Negotiate extended payment terms or restructure short-term liabilities to ease cash flow.
- Accelerate collection of receivables or convert some fixed assets into cash if possible.
Capital Injection ("Strengthen Immune System"):
- Seek additional equity investment from the controlling shareholder or external investors to improve net asset position and provide working capital buffer.
Debt Restructuring ("Relieve Stress on Vital Organs"):
- Engage creditors to restructure or refinance long-term debt to reduce immediate financial burden.
- Explore opportunities for loan interest reduction or covenant relaxation.
Operational Efficiency ("Optimize Function"):
- Monitor and control operating expenses tightly given the small scale.
- Consider strategic partnerships or outsourcing to reduce fixed costs.
Asset Review ("Assess Organ Health"):
- Conduct a valuation review of property assets to ensure balance sheet accuracy.
- Explore selling non-core or underperforming assets to raise cash.
Regular Financial Monitoring ("Continuous Health Check"):
- Implement monthly financial reviews focusing on cash flow forecasts and covenant compliance.
- Engage professional advice for ongoing financial and strategic planning.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.